Skip links

Indian biotech boom triggers surge in research startups – Nikkei Asian

Veena Rao, CEO of Vipragen, a startup founded in 2012 in Bangalore, said the drug-discovery environment has seen a surge of small companies. “Biotech companies need a strategic preclinical partner for performing discovery-driven, preclinical testing,” she said. “Also, the ability to offer cost-effective and quality service is one of the contributing factors in starting a [contract research] service company.”

Vipragen, which had revenues of 32 million rupees in the fiscal year ended March 2017, provides early-stage screening for safety and efficacy of drugs and chemicals before human use.

This website uses cookies to improve your web experience.